nodes	percent_of_prediction	percent_of_DWPC	metapath
Bicalutamide—CYP2C19—Efavirenz—acquired immunodeficiency syndrome	0.0322	0.0435	CbGbCtD
Bicalutamide—CYP2C19—Lopinavir—acquired immunodeficiency syndrome	0.0303	0.0409	CbGbCtD
Bicalutamide—CYP2C19—Amprenavir—acquired immunodeficiency syndrome	0.0274	0.037	CbGbCtD
Bicalutamide—CYP2C19—Delavirdine—acquired immunodeficiency syndrome	0.0274	0.037	CbGbCtD
Bicalutamide—CYP2C9—Efavirenz—acquired immunodeficiency syndrome	0.0268	0.0362	CbGbCtD
Bicalutamide—CYP2C9—Nevirapine—acquired immunodeficiency syndrome	0.0252	0.034	CbGbCtD
Bicalutamide—CYP2C9—Lopinavir—acquired immunodeficiency syndrome	0.0252	0.034	CbGbCtD
Bicalutamide—CYP2D6—Efavirenz—acquired immunodeficiency syndrome	0.0245	0.0331	CbGbCtD
Bicalutamide—CYP2C19—Indinavir—acquired immunodeficiency syndrome	0.0237	0.0319	CbGbCtD
Bicalutamide—CYP2D6—Lopinavir—acquired immunodeficiency syndrome	0.023	0.0311	CbGbCtD
Bicalutamide—CYP2D6—Nevirapine—acquired immunodeficiency syndrome	0.023	0.0311	CbGbCtD
Bicalutamide—CYP2C19—Nelfinavir—acquired immunodeficiency syndrome	0.023	0.031	CbGbCtD
Bicalutamide—CYP2C9—Delavirdine—acquired immunodeficiency syndrome	0.0228	0.0308	CbGbCtD
Bicalutamide—CYP2C9—Amprenavir—acquired immunodeficiency syndrome	0.0228	0.0308	CbGbCtD
Bicalutamide—CYP2D6—Amprenavir—acquired immunodeficiency syndrome	0.0208	0.0281	CbGbCtD
Bicalutamide—CYP2D6—Delavirdine—acquired immunodeficiency syndrome	0.0208	0.0281	CbGbCtD
Bicalutamide—CYP2C19—Ritonavir—acquired immunodeficiency syndrome	0.0208	0.028	CbGbCtD
Bicalutamide—CYP2C19—Saquinavir—acquired immunodeficiency syndrome	0.0208	0.028	CbGbCtD
Bicalutamide—CYP2C19—Zidovudine—acquired immunodeficiency syndrome	0.0199	0.0269	CbGbCtD
Bicalutamide—CYP2C9—Indinavir—acquired immunodeficiency syndrome	0.0197	0.0265	CbGbCtD
Bicalutamide—CYP2C9—Nelfinavir—acquired immunodeficiency syndrome	0.0191	0.0258	CbGbCtD
Bicalutamide—CYP2D6—Indinavir—acquired immunodeficiency syndrome	0.018	0.0243	CbGbCtD
Bicalutamide—CYP2D6—Nelfinavir—acquired immunodeficiency syndrome	0.0175	0.0236	CbGbCtD
Bicalutamide—CYP2C9—Ritonavir—acquired immunodeficiency syndrome	0.0173	0.0233	CbGbCtD
Bicalutamide—CYP2C9—Saquinavir—acquired immunodeficiency syndrome	0.0173	0.0233	CbGbCtD
Bicalutamide—CYP2C9—Zidovudine—acquired immunodeficiency syndrome	0.0166	0.0223	CbGbCtD
Bicalutamide—CYP2D6—Saquinavir—acquired immunodeficiency syndrome	0.0158	0.0213	CbGbCtD
Bicalutamide—CYP2D6—Ritonavir—acquired immunodeficiency syndrome	0.0158	0.0213	CbGbCtD
Bicalutamide—CYP3A4—Efavirenz—acquired immunodeficiency syndrome	0.0156	0.021	CbGbCtD
Bicalutamide—CYP3A4—Lopinavir—acquired immunodeficiency syndrome	0.0146	0.0198	CbGbCtD
Bicalutamide—CYP3A4—Nevirapine—acquired immunodeficiency syndrome	0.0146	0.0198	CbGbCtD
Bicalutamide—CYP3A4—Amprenavir—acquired immunodeficiency syndrome	0.0132	0.0179	CbGbCtD
Bicalutamide—CYP3A4—Delavirdine—acquired immunodeficiency syndrome	0.0132	0.0179	CbGbCtD
Bicalutamide—CYP3A4—Indinavir—acquired immunodeficiency syndrome	0.0114	0.0154	CbGbCtD
Bicalutamide—CYP3A4—Nelfinavir—acquired immunodeficiency syndrome	0.0111	0.015	CbGbCtD
Bicalutamide—CYP3A4—Saquinavir—acquired immunodeficiency syndrome	0.01	0.0136	CbGbCtD
Bicalutamide—CYP3A4—Ritonavir—acquired immunodeficiency syndrome	0.01	0.0136	CbGbCtD
Bicalutamide—CYP3A4—Zidovudine—acquired immunodeficiency syndrome	0.00963	0.013	CbGbCtD
Bicalutamide—AR—semen—acquired immunodeficiency syndrome	0.00429	0.224	CbGeAlD
Bicalutamide—Enzalutamide—ALB—acquired immunodeficiency syndrome	0.00187	1	CrCbGaD
Bicalutamide—CYP2C19—blood plasma—acquired immunodeficiency syndrome	0.00145	0.0756	CbGeAlD
Bicalutamide—CYP2C9—blood plasma—acquired immunodeficiency syndrome	0.00112	0.0586	CbGeAlD
Bicalutamide—CYP3A4—blood plasma—acquired immunodeficiency syndrome	0.000855	0.0447	CbGeAlD
Bicalutamide—CYP2D6—blood plasma—acquired immunodeficiency syndrome	0.000842	0.044	CbGeAlD
Bicalutamide—AR—skin of body—acquired immunodeficiency syndrome	0.000751	0.0392	CbGeAlD
Bicalutamide—AR—lymphoid tissue—acquired immunodeficiency syndrome	0.000608	0.0317	CbGeAlD
Bicalutamide—AR—digestive system—acquired immunodeficiency syndrome	0.000601	0.0314	CbGeAlD
Bicalutamide—AR—blood—acquired immunodeficiency syndrome	0.000572	0.0299	CbGeAlD
Bicalutamide—CYP2C19—digestive system—acquired immunodeficiency syndrome	0.000556	0.0291	CbGeAlD
Bicalutamide—AR—spinal cord—acquired immunodeficiency syndrome	0.000551	0.0288	CbGeAlD
Bicalutamide—AR—vagina—acquired immunodeficiency syndrome	0.00053	0.0277	CbGeAlD
Bicalutamide—CYP2C19—blood—acquired immunodeficiency syndrome	0.00053	0.0277	CbGeAlD
Bicalutamide—AR—lung—acquired immunodeficiency syndrome	0.000502	0.0262	CbGeAlD
Bicalutamide—CYP2C19—vagina—acquired immunodeficiency syndrome	0.000491	0.0257	CbGeAlD
Bicalutamide—AR—nervous system—acquired immunodeficiency syndrome	0.000464	0.0243	CbGeAlD
Bicalutamide—AR—central nervous system—acquired immunodeficiency syndrome	0.000447	0.0234	CbGeAlD
Bicalutamide—CYP2C9—digestive system—acquired immunodeficiency syndrome	0.000431	0.0225	CbGeAlD
Bicalutamide—CYP2C9—blood—acquired immunodeficiency syndrome	0.000411	0.0215	CbGeAlD
Bicalutamide—AR—brain—acquired immunodeficiency syndrome	0.000355	0.0185	CbGeAlD
Bicalutamide—AR—lymph node—acquired immunodeficiency syndrome	0.000343	0.0179	CbGeAlD
Bicalutamide—CYP3A4—digestive system—acquired immunodeficiency syndrome	0.000329	0.0172	CbGeAlD
Bicalutamide—CYP2D6—digestive system—acquired immunodeficiency syndrome	0.000324	0.0169	CbGeAlD
Bicalutamide—CYP3A4—blood—acquired immunodeficiency syndrome	0.000313	0.0164	CbGeAlD
Bicalutamide—CYP2D6—blood—acquired immunodeficiency syndrome	0.000308	0.0161	CbGeAlD
Bicalutamide—CYP3A4—nervous system—acquired immunodeficiency syndrome	0.000254	0.0133	CbGeAlD
Bicalutamide—CYP2D6—nervous system—acquired immunodeficiency syndrome	0.00025	0.0131	CbGeAlD
Bicalutamide—CYP3A4—central nervous system—acquired immunodeficiency syndrome	0.000245	0.0128	CbGeAlD
Bicalutamide—CYP2D6—central nervous system—acquired immunodeficiency syndrome	0.000241	0.0126	CbGeAlD
Bicalutamide—CYP2D6—brain—acquired immunodeficiency syndrome	0.000191	0.00999	CbGeAlD
Bicalutamide—Hypertension—Ritonavir—acquired immunodeficiency syndrome	0.000132	0.000555	CcSEcCtD
Bicalutamide—Syncope—Saquinavir—acquired immunodeficiency syndrome	0.000132	0.000555	CcSEcCtD
Bicalutamide—Dyspepsia—Indinavir—acquired immunodeficiency syndrome	0.000132	0.000552	CcSEcCtD
Bicalutamide—Gastrointestinal pain—Zidovudine—acquired immunodeficiency syndrome	0.000131	0.000552	CcSEcCtD
Bicalutamide—Skin disorder—Delavirdine—acquired immunodeficiency syndrome	0.000131	0.000551	CcSEcCtD
Bicalutamide—Pruritus—Nelfinavir—acquired immunodeficiency syndrome	0.000131	0.000551	CcSEcCtD
Bicalutamide—Diarrhoea—Nevirapine—acquired immunodeficiency syndrome	0.000131	0.00055	CcSEcCtD
Bicalutamide—Pruritus—Stavudine—acquired immunodeficiency syndrome	0.000131	0.000549	CcSEcCtD
Bicalutamide—Asthenia—Abacavir—acquired immunodeficiency syndrome	0.000131	0.000549	CcSEcCtD
Bicalutamide—Hyperhidrosis—Delavirdine—acquired immunodeficiency syndrome	0.000131	0.000548	CcSEcCtD
Bicalutamide—Chest pain—Ritonavir—acquired immunodeficiency syndrome	0.00013	0.000547	CcSEcCtD
Bicalutamide—Myalgia—Ritonavir—acquired immunodeficiency syndrome	0.00013	0.000547	CcSEcCtD
Bicalutamide—Decreased appetite—Indinavir—acquired immunodeficiency syndrome	0.00013	0.000546	CcSEcCtD
Bicalutamide—Anaemia—Lamivudine—acquired immunodeficiency syndrome	0.00013	0.000546	CcSEcCtD
Bicalutamide—Anxiety—Ritonavir—acquired immunodeficiency syndrome	0.00013	0.000545	CcSEcCtD
Bicalutamide—Loss of consciousness—Saquinavir—acquired immunodeficiency syndrome	0.000129	0.000544	CcSEcCtD
Bicalutamide—Unspecified disorder of skin and subcutaneous tissue—Ritonavir—acquired immunodeficiency syndrome	0.000129	0.000543	CcSEcCtD
Bicalutamide—Gastrointestinal disorder—Indinavir—acquired immunodeficiency syndrome	0.000129	0.000542	CcSEcCtD
Bicalutamide—Pruritus—Abacavir—acquired immunodeficiency syndrome	0.000129	0.000541	CcSEcCtD
Bicalutamide—Fatigue—Indinavir—acquired immunodeficiency syndrome	0.000129	0.000541	CcSEcCtD
Bicalutamide—Anorexia—Delavirdine—acquired immunodeficiency syndrome	0.000129	0.000541	CcSEcCtD
Bicalutamide—Musculoskeletal discomfort—Efavirenz—acquired immunodeficiency syndrome	0.000129	0.00054	CcSEcCtD
Bicalutamide—Cough—Saquinavir—acquired immunodeficiency syndrome	0.000129	0.00054	CcSEcCtD
Bicalutamide—Angioedema—Lamivudine—acquired immunodeficiency syndrome	0.000128	0.000539	CcSEcCtD
Bicalutamide—Pain—Indinavir—acquired immunodeficiency syndrome	0.000128	0.000537	CcSEcCtD
Bicalutamide—Constipation—Indinavir—acquired immunodeficiency syndrome	0.000128	0.000537	CcSEcCtD
Bicalutamide—Insomnia—Efavirenz—acquired immunodeficiency syndrome	0.000128	0.000536	CcSEcCtD
Bicalutamide—Urticaria—Zidovudine—acquired immunodeficiency syndrome	0.000128	0.000536	CcSEcCtD
Bicalutamide—Dry mouth—Ritonavir—acquired immunodeficiency syndrome	0.000127	0.000535	CcSEcCtD
Bicalutamide—Hypertension—Saquinavir—acquired immunodeficiency syndrome	0.000127	0.000534	CcSEcCtD
Bicalutamide—Body temperature increased—Zidovudine—acquired immunodeficiency syndrome	0.000127	0.000533	CcSEcCtD
Bicalutamide—Abdominal pain—Zidovudine—acquired immunodeficiency syndrome	0.000127	0.000533	CcSEcCtD
Bicalutamide—Diarrhoea—Nelfinavir—acquired immunodeficiency syndrome	0.000127	0.000533	CcSEcCtD
Bicalutamide—Paraesthesia—Efavirenz—acquired immunodeficiency syndrome	0.000127	0.000532	CcSEcCtD
Bicalutamide—Diarrhoea—Stavudine—acquired immunodeficiency syndrome	0.000126	0.000531	CcSEcCtD
Bicalutamide—Nausea—Didanosine—acquired immunodeficiency syndrome	0.000126	0.000531	CcSEcCtD
Bicalutamide—Syncope—Lamivudine—acquired immunodeficiency syndrome	0.000126	0.000529	CcSEcCtD
Bicalutamide—Confusional state—Ritonavir—acquired immunodeficiency syndrome	0.000126	0.000529	CcSEcCtD
Bicalutamide—Dyspnoea—Efavirenz—acquired immunodeficiency syndrome	0.000126	0.000529	CcSEcCtD
Bicalutamide—Somnolence—Efavirenz—acquired immunodeficiency syndrome	0.000125	0.000527	CcSEcCtD
Bicalutamide—Chest pain—Saquinavir—acquired immunodeficiency syndrome	0.000125	0.000527	CcSEcCtD
Bicalutamide—Myalgia—Saquinavir—acquired immunodeficiency syndrome	0.000125	0.000527	CcSEcCtD
Bicalutamide—Anxiety—Saquinavir—acquired immunodeficiency syndrome	0.000125	0.000525	CcSEcCtD
Bicalutamide—Oedema—Ritonavir—acquired immunodeficiency syndrome	0.000125	0.000525	CcSEcCtD
Bicalutamide—Diarrhoea—Abacavir—acquired immunodeficiency syndrome	0.000125	0.000523	CcSEcCtD
Bicalutamide—Unspecified disorder of skin and subcutaneous tissue—Saquinavir—acquired immunodeficiency syndrome	0.000125	0.000523	CcSEcCtD
Bicalutamide—Dyspepsia—Efavirenz—acquired immunodeficiency syndrome	0.000124	0.000522	CcSEcCtD
Bicalutamide—Loss of consciousness—Lamivudine—acquired immunodeficiency syndrome	0.000124	0.000519	CcSEcCtD
Bicalutamide—Feeling abnormal—Indinavir—acquired immunodeficiency syndrome	0.000123	0.000517	CcSEcCtD
Bicalutamide—Musculoskeletal discomfort—Delavirdine—acquired immunodeficiency syndrome	0.000123	0.000517	CcSEcCtD
Bicalutamide—Shock—Ritonavir—acquired immunodeficiency syndrome	0.000123	0.000516	CcSEcCtD
Bicalutamide—Decreased appetite—Efavirenz—acquired immunodeficiency syndrome	0.000123	0.000515	CcSEcCtD
Bicalutamide—Dry mouth—Saquinavir—acquired immunodeficiency syndrome	0.000123	0.000515	CcSEcCtD
Bicalutamide—Cough—Lamivudine—acquired immunodeficiency syndrome	0.000123	0.000515	CcSEcCtD
Bicalutamide—Dizziness—Nelfinavir—acquired immunodeficiency syndrome	0.000123	0.000515	CcSEcCtD
Bicalutamide—Nervous system disorder—Ritonavir—acquired immunodeficiency syndrome	0.000122	0.000514	CcSEcCtD
Bicalutamide—Thrombocytopenia—Ritonavir—acquired immunodeficiency syndrome	0.000122	0.000514	CcSEcCtD
Bicalutamide—Dizziness—Stavudine—acquired immunodeficiency syndrome	0.000122	0.000513	CcSEcCtD
Bicalutamide—Gastrointestinal pain—Indinavir—acquired immunodeficiency syndrome	0.000122	0.000513	CcSEcCtD
Bicalutamide—Insomnia—Delavirdine—acquired immunodeficiency syndrome	0.000122	0.000513	CcSEcCtD
Bicalutamide—Gastrointestinal disorder—Efavirenz—acquired immunodeficiency syndrome	0.000122	0.000512	CcSEcCtD
Bicalutamide—Vomiting—Nevirapine—acquired immunodeficiency syndrome	0.000122	0.000511	CcSEcCtD
Bicalutamide—Fatigue—Efavirenz—acquired immunodeficiency syndrome	0.000122	0.000511	CcSEcCtD
Bicalutamide—Skin disorder—Ritonavir—acquired immunodeficiency syndrome	0.000121	0.00051	CcSEcCtD
Bicalutamide—Paraesthesia—Delavirdine—acquired immunodeficiency syndrome	0.000121	0.000509	CcSEcCtD
Bicalutamide—Confusional state—Saquinavir—acquired immunodeficiency syndrome	0.000121	0.000509	CcSEcCtD
Bicalutamide—Hyperhidrosis—Ritonavir—acquired immunodeficiency syndrome	0.000121	0.000507	CcSEcCtD
Bicalutamide—Pain—Efavirenz—acquired immunodeficiency syndrome	0.000121	0.000507	CcSEcCtD
Bicalutamide—Constipation—Efavirenz—acquired immunodeficiency syndrome	0.000121	0.000507	CcSEcCtD
Bicalutamide—Rash—Nevirapine—acquired immunodeficiency syndrome	0.000121	0.000507	CcSEcCtD
Bicalutamide—Dermatitis—Nevirapine—acquired immunodeficiency syndrome	0.000121	0.000507	CcSEcCtD
Bicalutamide—Dyspnoea—Delavirdine—acquired immunodeficiency syndrome	0.00012	0.000506	CcSEcCtD
Bicalutamide—Dizziness—Abacavir—acquired immunodeficiency syndrome	0.00012	0.000506	CcSEcCtD
Bicalutamide—Oedema—Saquinavir—acquired immunodeficiency syndrome	0.00012	0.000505	CcSEcCtD
Bicalutamide—Somnolence—Delavirdine—acquired immunodeficiency syndrome	0.00012	0.000504	CcSEcCtD
Bicalutamide—Headache—Nevirapine—acquired immunodeficiency syndrome	0.00012	0.000504	CcSEcCtD
Bicalutamide—Chest pain—Lamivudine—acquired immunodeficiency syndrome	0.00012	0.000502	CcSEcCtD
Bicalutamide—Myalgia—Lamivudine—acquired immunodeficiency syndrome	0.00012	0.000502	CcSEcCtD
Bicalutamide—Infection—Saquinavir—acquired immunodeficiency syndrome	0.000119	0.000502	CcSEcCtD
Bicalutamide—Anxiety—Lamivudine—acquired immunodeficiency syndrome	0.000119	0.000501	CcSEcCtD
Bicalutamide—Anorexia—Ritonavir—acquired immunodeficiency syndrome	0.000119	0.0005	CcSEcCtD
Bicalutamide—Dyspepsia—Delavirdine—acquired immunodeficiency syndrome	0.000119	0.000499	CcSEcCtD
Bicalutamide—Unspecified disorder of skin and subcutaneous tissue—Lamivudine—acquired immunodeficiency syndrome	0.000119	0.000499	CcSEcCtD
Bicalutamide—Urticaria—Indinavir—acquired immunodeficiency syndrome	0.000119	0.000499	CcSEcCtD
Bicalutamide—Shock—Saquinavir—acquired immunodeficiency syndrome	0.000118	0.000497	CcSEcCtD
Bicalutamide—Body temperature increased—Indinavir—acquired immunodeficiency syndrome	0.000118	0.000496	CcSEcCtD
Bicalutamide—Abdominal pain—Indinavir—acquired immunodeficiency syndrome	0.000118	0.000496	CcSEcCtD
Bicalutamide—Nervous system disorder—Saquinavir—acquired immunodeficiency syndrome	0.000118	0.000495	CcSEcCtD
Bicalutamide—Vomiting—Nelfinavir—acquired immunodeficiency syndrome	0.000118	0.000495	CcSEcCtD
Bicalutamide—Thrombocytopenia—Saquinavir—acquired immunodeficiency syndrome	0.000118	0.000494	CcSEcCtD
Bicalutamide—Vomiting—Stavudine—acquired immunodeficiency syndrome	0.000118	0.000494	CcSEcCtD
Bicalutamide—Decreased appetite—Delavirdine—acquired immunodeficiency syndrome	0.000117	0.000493	CcSEcCtD
Bicalutamide—Dry mouth—Lamivudine—acquired immunodeficiency syndrome	0.000117	0.000491	CcSEcCtD
Bicalutamide—Rash—Nelfinavir—acquired immunodeficiency syndrome	0.000117	0.000491	CcSEcCtD
Bicalutamide—Dermatitis—Nelfinavir—acquired immunodeficiency syndrome	0.000117	0.000491	CcSEcCtD
Bicalutamide—Skin disorder—Saquinavir—acquired immunodeficiency syndrome	0.000117	0.00049	CcSEcCtD
Bicalutamide—Gastrointestinal disorder—Delavirdine—acquired immunodeficiency syndrome	0.000117	0.00049	CcSEcCtD
Bicalutamide—Rash—Stavudine—acquired immunodeficiency syndrome	0.000117	0.000489	CcSEcCtD
Bicalutamide—Fatigue—Delavirdine—acquired immunodeficiency syndrome	0.000116	0.000489	CcSEcCtD
Bicalutamide—Dermatitis—Stavudine—acquired immunodeficiency syndrome	0.000116	0.000489	CcSEcCtD
Bicalutamide—Feeling abnormal—Efavirenz—acquired immunodeficiency syndrome	0.000116	0.000489	CcSEcCtD
Bicalutamide—Hyperhidrosis—Saquinavir—acquired immunodeficiency syndrome	0.000116	0.000488	CcSEcCtD
Bicalutamide—Headache—Nelfinavir—acquired immunodeficiency syndrome	0.000116	0.000488	CcSEcCtD
Bicalutamide—Headache—Stavudine—acquired immunodeficiency syndrome	0.000116	0.000486	CcSEcCtD
Bicalutamide—Vomiting—Abacavir—acquired immunodeficiency syndrome	0.000116	0.000486	CcSEcCtD
Bicalutamide—Confusional state—Lamivudine—acquired immunodeficiency syndrome	0.000116	0.000486	CcSEcCtD
Bicalutamide—Pain—Delavirdine—acquired immunodeficiency syndrome	0.000115	0.000485	CcSEcCtD
Bicalutamide—Constipation—Delavirdine—acquired immunodeficiency syndrome	0.000115	0.000485	CcSEcCtD
Bicalutamide—Gastrointestinal pain—Efavirenz—acquired immunodeficiency syndrome	0.000115	0.000485	CcSEcCtD
Bicalutamide—Asthenia—Zidovudine—acquired immunodeficiency syndrome	0.000115	0.000484	CcSEcCtD
Bicalutamide—Rash—Abacavir—acquired immunodeficiency syndrome	0.000115	0.000482	CcSEcCtD
Bicalutamide—Dermatitis—Abacavir—acquired immunodeficiency syndrome	0.000115	0.000482	CcSEcCtD
Bicalutamide—Oedema—Lamivudine—acquired immunodeficiency syndrome	0.000115	0.000482	CcSEcCtD
Bicalutamide—Anorexia—Saquinavir—acquired immunodeficiency syndrome	0.000115	0.000481	CcSEcCtD
Bicalutamide—Headache—Abacavir—acquired immunodeficiency syndrome	0.000114	0.000479	CcSEcCtD
Bicalutamide—Infection—Lamivudine—acquired immunodeficiency syndrome	0.000114	0.000479	CcSEcCtD
Bicalutamide—Musculoskeletal discomfort—Ritonavir—acquired immunodeficiency syndrome	0.000114	0.000478	CcSEcCtD
Bicalutamide—Nausea—Nevirapine—acquired immunodeficiency syndrome	0.000114	0.000478	CcSEcCtD
Bicalutamide—Pruritus—Zidovudine—acquired immunodeficiency syndrome	0.000114	0.000477	CcSEcCtD
Bicalutamide—Insomnia—Ritonavir—acquired immunodeficiency syndrome	0.000113	0.000474	CcSEcCtD
Bicalutamide—Shock—Lamivudine—acquired immunodeficiency syndrome	0.000113	0.000474	CcSEcCtD
Bicalutamide—Nervous system disorder—Lamivudine—acquired immunodeficiency syndrome	0.000112	0.000472	CcSEcCtD
Bicalutamide—Thrombocytopenia—Lamivudine—acquired immunodeficiency syndrome	0.000112	0.000472	CcSEcCtD
Bicalutamide—Paraesthesia—Ritonavir—acquired immunodeficiency syndrome	0.000112	0.000471	CcSEcCtD
Bicalutamide—Urticaria—Efavirenz—acquired immunodeficiency syndrome	0.000112	0.000471	CcSEcCtD
Bicalutamide—Abdominal pain—Efavirenz—acquired immunodeficiency syndrome	0.000112	0.000469	CcSEcCtD
Bicalutamide—Body temperature increased—Efavirenz—acquired immunodeficiency syndrome	0.000112	0.000469	CcSEcCtD
Bicalutamide—Skin disorder—Lamivudine—acquired immunodeficiency syndrome	0.000111	0.000468	CcSEcCtD
Bicalutamide—Dyspnoea—Ritonavir—acquired immunodeficiency syndrome	0.000111	0.000468	CcSEcCtD
Bicalutamide—Feeling abnormal—Delavirdine—acquired immunodeficiency syndrome	0.000111	0.000467	CcSEcCtD
Bicalutamide—Somnolence—Ritonavir—acquired immunodeficiency syndrome	0.000111	0.000466	CcSEcCtD
Bicalutamide—Hyperhidrosis—Lamivudine—acquired immunodeficiency syndrome	0.000111	0.000466	CcSEcCtD
Bicalutamide—Gastrointestinal pain—Delavirdine—acquired immunodeficiency syndrome	0.00011	0.000464	CcSEcCtD
Bicalutamide—Nausea—Nelfinavir—acquired immunodeficiency syndrome	0.00011	0.000463	CcSEcCtD
Bicalutamide—Hypersensitivity—Indinavir—acquired immunodeficiency syndrome	0.00011	0.000462	CcSEcCtD
Bicalutamide—Dyspepsia—Ritonavir—acquired immunodeficiency syndrome	0.00011	0.000462	CcSEcCtD
Bicalutamide—Diarrhoea—Zidovudine—acquired immunodeficiency syndrome	0.00011	0.000462	CcSEcCtD
Bicalutamide—Nausea—Stavudine—acquired immunodeficiency syndrome	0.00011	0.000461	CcSEcCtD
Bicalutamide—Musculoskeletal discomfort—Saquinavir—acquired immunodeficiency syndrome	0.00011	0.00046	CcSEcCtD
Bicalutamide—Anorexia—Lamivudine—acquired immunodeficiency syndrome	0.000109	0.000459	CcSEcCtD
Bicalutamide—Insomnia—Saquinavir—acquired immunodeficiency syndrome	0.000109	0.000457	CcSEcCtD
Bicalutamide—Decreased appetite—Ritonavir—acquired immunodeficiency syndrome	0.000109	0.000456	CcSEcCtD
Bicalutamide—Nausea—Abacavir—acquired immunodeficiency syndrome	0.000108	0.000454	CcSEcCtD
Bicalutamide—Paraesthesia—Saquinavir—acquired immunodeficiency syndrome	0.000108	0.000453	CcSEcCtD
Bicalutamide—Gastrointestinal disorder—Ritonavir—acquired immunodeficiency syndrome	0.000108	0.000453	CcSEcCtD
Bicalutamide—Fatigue—Ritonavir—acquired immunodeficiency syndrome	0.000108	0.000452	CcSEcCtD
Bicalutamide—Urticaria—Delavirdine—acquired immunodeficiency syndrome	0.000107	0.000451	CcSEcCtD
Bicalutamide—Asthenia—Indinavir—acquired immunodeficiency syndrome	0.000107	0.00045	CcSEcCtD
Bicalutamide—Dyspnoea—Saquinavir—acquired immunodeficiency syndrome	0.000107	0.00045	CcSEcCtD
Bicalutamide—Somnolence—Saquinavir—acquired immunodeficiency syndrome	0.000107	0.000449	CcSEcCtD
Bicalutamide—Pain—Ritonavir—acquired immunodeficiency syndrome	0.000107	0.000449	CcSEcCtD
Bicalutamide—Constipation—Ritonavir—acquired immunodeficiency syndrome	0.000107	0.000449	CcSEcCtD
Bicalutamide—Abdominal pain—Delavirdine—acquired immunodeficiency syndrome	0.000107	0.000448	CcSEcCtD
Bicalutamide—Body temperature increased—Delavirdine—acquired immunodeficiency syndrome	0.000107	0.000448	CcSEcCtD
Bicalutamide—Dizziness—Zidovudine—acquired immunodeficiency syndrome	0.000106	0.000446	CcSEcCtD
Bicalutamide—Dyspepsia—Saquinavir—acquired immunodeficiency syndrome	0.000106	0.000444	CcSEcCtD
Bicalutamide—Pruritus—Indinavir—acquired immunodeficiency syndrome	0.000106	0.000444	CcSEcCtD
Bicalutamide—Decreased appetite—Saquinavir—acquired immunodeficiency syndrome	0.000104	0.000439	CcSEcCtD
Bicalutamide—Musculoskeletal discomfort—Lamivudine—acquired immunodeficiency syndrome	0.000104	0.000439	CcSEcCtD
Bicalutamide—Hypersensitivity—Efavirenz—acquired immunodeficiency syndrome	0.000104	0.000437	CcSEcCtD
Bicalutamide—Gastrointestinal disorder—Saquinavir—acquired immunodeficiency syndrome	0.000104	0.000436	CcSEcCtD
Bicalutamide—Insomnia—Lamivudine—acquired immunodeficiency syndrome	0.000104	0.000436	CcSEcCtD
Bicalutamide—Fatigue—Saquinavir—acquired immunodeficiency syndrome	0.000104	0.000435	CcSEcCtD
Bicalutamide—Paraesthesia—Lamivudine—acquired immunodeficiency syndrome	0.000103	0.000433	CcSEcCtD
Bicalutamide—Feeling abnormal—Ritonavir—acquired immunodeficiency syndrome	0.000103	0.000432	CcSEcCtD
Bicalutamide—Constipation—Saquinavir—acquired immunodeficiency syndrome	0.000103	0.000432	CcSEcCtD
Bicalutamide—Pain—Saquinavir—acquired immunodeficiency syndrome	0.000103	0.000432	CcSEcCtD
Bicalutamide—Dyspnoea—Lamivudine—acquired immunodeficiency syndrome	0.000102	0.000429	CcSEcCtD
Bicalutamide—Diarrhoea—Indinavir—acquired immunodeficiency syndrome	0.000102	0.000429	CcSEcCtD
Bicalutamide—Vomiting—Zidovudine—acquired immunodeficiency syndrome	0.000102	0.000429	CcSEcCtD
Bicalutamide—Gastrointestinal pain—Ritonavir—acquired immunodeficiency syndrome	0.000102	0.000429	CcSEcCtD
Bicalutamide—Somnolence—Lamivudine—acquired immunodeficiency syndrome	0.000102	0.000428	CcSEcCtD
Bicalutamide—Rash—Zidovudine—acquired immunodeficiency syndrome	0.000101	0.000425	CcSEcCtD
Bicalutamide—Asthenia—Efavirenz—acquired immunodeficiency syndrome	0.000101	0.000425	CcSEcCtD
Bicalutamide—Dermatitis—Zidovudine—acquired immunodeficiency syndrome	0.000101	0.000425	CcSEcCtD
Bicalutamide—Dyspepsia—Lamivudine—acquired immunodeficiency syndrome	0.000101	0.000424	CcSEcCtD
Bicalutamide—Headache—Zidovudine—acquired immunodeficiency syndrome	0.000101	0.000423	CcSEcCtD
Bicalutamide—Pruritus—Efavirenz—acquired immunodeficiency syndrome	9.99e-05	0.000419	CcSEcCtD
Bicalutamide—Decreased appetite—Lamivudine—acquired immunodeficiency syndrome	9.97e-05	0.000419	CcSEcCtD
Bicalutamide—Hypersensitivity—Delavirdine—acquired immunodeficiency syndrome	9.95e-05	0.000418	CcSEcCtD
Bicalutamide—Urticaria—Ritonavir—acquired immunodeficiency syndrome	9.92e-05	0.000417	CcSEcCtD
Bicalutamide—Feeling abnormal—Saquinavir—acquired immunodeficiency syndrome	9.91e-05	0.000416	CcSEcCtD
Bicalutamide—Gastrointestinal disorder—Lamivudine—acquired immunodeficiency syndrome	9.9e-05	0.000416	CcSEcCtD
Bicalutamide—Fatigue—Lamivudine—acquired immunodeficiency syndrome	9.89e-05	0.000415	CcSEcCtD
Bicalutamide—Dizziness—Indinavir—acquired immunodeficiency syndrome	9.88e-05	0.000415	CcSEcCtD
Bicalutamide—Body temperature increased—Ritonavir—acquired immunodeficiency syndrome	9.87e-05	0.000415	CcSEcCtD
Bicalutamide—Abdominal pain—Ritonavir—acquired immunodeficiency syndrome	9.87e-05	0.000415	CcSEcCtD
Bicalutamide—Gastrointestinal pain—Saquinavir—acquired immunodeficiency syndrome	9.83e-05	0.000413	CcSEcCtD
Bicalutamide—Pain—Lamivudine—acquired immunodeficiency syndrome	9.81e-05	0.000412	CcSEcCtD
Bicalutamide—Constipation—Lamivudine—acquired immunodeficiency syndrome	9.81e-05	0.000412	CcSEcCtD
Bicalutamide—Asthenia—Delavirdine—acquired immunodeficiency syndrome	9.69e-05	0.000407	CcSEcCtD
Bicalutamide—Diarrhoea—Efavirenz—acquired immunodeficiency syndrome	9.66e-05	0.000406	CcSEcCtD
Bicalutamide—Pruritus—Delavirdine—acquired immunodeficiency syndrome	9.56e-05	0.000401	CcSEcCtD
Bicalutamide—Urticaria—Saquinavir—acquired immunodeficiency syndrome	9.55e-05	0.000401	CcSEcCtD
Bicalutamide—Nausea—Zidovudine—acquired immunodeficiency syndrome	9.54e-05	0.000401	CcSEcCtD
Bicalutamide—Abdominal pain—Saquinavir—acquired immunodeficiency syndrome	9.5e-05	0.000399	CcSEcCtD
Bicalutamide—Body temperature increased—Saquinavir—acquired immunodeficiency syndrome	9.5e-05	0.000399	CcSEcCtD
Bicalutamide—Vomiting—Indinavir—acquired immunodeficiency syndrome	9.5e-05	0.000399	CcSEcCtD
Bicalutamide—Feeling abnormal—Lamivudine—acquired immunodeficiency syndrome	9.45e-05	0.000397	CcSEcCtD
Bicalutamide—Rash—Indinavir—acquired immunodeficiency syndrome	9.42e-05	0.000396	CcSEcCtD
Bicalutamide—Dermatitis—Indinavir—acquired immunodeficiency syndrome	9.41e-05	0.000395	CcSEcCtD
Bicalutamide—Gastrointestinal pain—Lamivudine—acquired immunodeficiency syndrome	9.38e-05	0.000394	CcSEcCtD
Bicalutamide—Headache—Indinavir—acquired immunodeficiency syndrome	9.36e-05	0.000393	CcSEcCtD
Bicalutamide—Dizziness—Efavirenz—acquired immunodeficiency syndrome	9.33e-05	0.000392	CcSEcCtD
Bicalutamide—Diarrhoea—Delavirdine—acquired immunodeficiency syndrome	9.24e-05	0.000388	CcSEcCtD
Bicalutamide—Hypersensitivity—Ritonavir—acquired immunodeficiency syndrome	9.2e-05	0.000387	CcSEcCtD
Bicalutamide—Urticaria—Lamivudine—acquired immunodeficiency syndrome	9.11e-05	0.000383	CcSEcCtD
Bicalutamide—Body temperature increased—Lamivudine—acquired immunodeficiency syndrome	9.07e-05	0.000381	CcSEcCtD
Bicalutamide—Abdominal pain—Lamivudine—acquired immunodeficiency syndrome	9.07e-05	0.000381	CcSEcCtD
Bicalutamide—Vomiting—Efavirenz—acquired immunodeficiency syndrome	8.98e-05	0.000377	CcSEcCtD
Bicalutamide—Asthenia—Ritonavir—acquired immunodeficiency syndrome	8.96e-05	0.000376	CcSEcCtD
Bicalutamide—Dizziness—Delavirdine—acquired immunodeficiency syndrome	8.93e-05	0.000375	CcSEcCtD
Bicalutamide—Rash—Efavirenz—acquired immunodeficiency syndrome	8.9e-05	0.000374	CcSEcCtD
Bicalutamide—Dermatitis—Efavirenz—acquired immunodeficiency syndrome	8.89e-05	0.000373	CcSEcCtD
Bicalutamide—Nausea—Indinavir—acquired immunodeficiency syndrome	8.87e-05	0.000373	CcSEcCtD
Bicalutamide—Hypersensitivity—Saquinavir—acquired immunodeficiency syndrome	8.86e-05	0.000372	CcSEcCtD
Bicalutamide—Headache—Efavirenz—acquired immunodeficiency syndrome	8.84e-05	0.000371	CcSEcCtD
Bicalutamide—Pruritus—Ritonavir—acquired immunodeficiency syndrome	8.84e-05	0.000371	CcSEcCtD
Bicalutamide—Asthenia—Saquinavir—acquired immunodeficiency syndrome	8.62e-05	0.000362	CcSEcCtD
Bicalutamide—Vomiting—Delavirdine—acquired immunodeficiency syndrome	8.59e-05	0.000361	CcSEcCtD
Bicalutamide—Diarrhoea—Ritonavir—acquired immunodeficiency syndrome	8.55e-05	0.000359	CcSEcCtD
Bicalutamide—Rash—Delavirdine—acquired immunodeficiency syndrome	8.52e-05	0.000358	CcSEcCtD
Bicalutamide—Dermatitis—Delavirdine—acquired immunodeficiency syndrome	8.51e-05	0.000357	CcSEcCtD
Bicalutamide—Pruritus—Saquinavir—acquired immunodeficiency syndrome	8.5e-05	0.000357	CcSEcCtD
Bicalutamide—Headache—Delavirdine—acquired immunodeficiency syndrome	8.46e-05	0.000355	CcSEcCtD
Bicalutamide—Hypersensitivity—Lamivudine—acquired immunodeficiency syndrome	8.45e-05	0.000355	CcSEcCtD
Bicalutamide—Nausea—Efavirenz—acquired immunodeficiency syndrome	8.38e-05	0.000352	CcSEcCtD
Bicalutamide—Dizziness—Ritonavir—acquired immunodeficiency syndrome	8.26e-05	0.000347	CcSEcCtD
Bicalutamide—Asthenia—Lamivudine—acquired immunodeficiency syndrome	8.23e-05	0.000346	CcSEcCtD
Bicalutamide—Diarrhoea—Saquinavir—acquired immunodeficiency syndrome	8.22e-05	0.000345	CcSEcCtD
Bicalutamide—Pruritus—Lamivudine—acquired immunodeficiency syndrome	8.11e-05	0.000341	CcSEcCtD
Bicalutamide—Nausea—Delavirdine—acquired immunodeficiency syndrome	8.02e-05	0.000337	CcSEcCtD
Bicalutamide—Dizziness—Saquinavir—acquired immunodeficiency syndrome	7.95e-05	0.000334	CcSEcCtD
Bicalutamide—Vomiting—Ritonavir—acquired immunodeficiency syndrome	7.94e-05	0.000334	CcSEcCtD
Bicalutamide—Rash—Ritonavir—acquired immunodeficiency syndrome	7.87e-05	0.000331	CcSEcCtD
Bicalutamide—Dermatitis—Ritonavir—acquired immunodeficiency syndrome	7.87e-05	0.00033	CcSEcCtD
Bicalutamide—Diarrhoea—Lamivudine—acquired immunodeficiency syndrome	7.85e-05	0.00033	CcSEcCtD
Bicalutamide—Headache—Ritonavir—acquired immunodeficiency syndrome	7.82e-05	0.000329	CcSEcCtD
Bicalutamide—Vomiting—Saquinavir—acquired immunodeficiency syndrome	7.64e-05	0.000321	CcSEcCtD
Bicalutamide—Dizziness—Lamivudine—acquired immunodeficiency syndrome	7.58e-05	0.000319	CcSEcCtD
Bicalutamide—Rash—Saquinavir—acquired immunodeficiency syndrome	7.58e-05	0.000318	CcSEcCtD
Bicalutamide—Dermatitis—Saquinavir—acquired immunodeficiency syndrome	7.57e-05	0.000318	CcSEcCtD
Bicalutamide—Headache—Saquinavir—acquired immunodeficiency syndrome	7.53e-05	0.000316	CcSEcCtD
Bicalutamide—Nausea—Ritonavir—acquired immunodeficiency syndrome	7.42e-05	0.000312	CcSEcCtD
Bicalutamide—Vomiting—Lamivudine—acquired immunodeficiency syndrome	7.29e-05	0.000306	CcSEcCtD
Bicalutamide—Rash—Lamivudine—acquired immunodeficiency syndrome	7.23e-05	0.000304	CcSEcCtD
Bicalutamide—Dermatitis—Lamivudine—acquired immunodeficiency syndrome	7.22e-05	0.000303	CcSEcCtD
Bicalutamide—Headache—Lamivudine—acquired immunodeficiency syndrome	7.18e-05	0.000302	CcSEcCtD
Bicalutamide—Nausea—Saquinavir—acquired immunodeficiency syndrome	7.14e-05	0.0003	CcSEcCtD
Bicalutamide—Nausea—Lamivudine—acquired immunodeficiency syndrome	6.81e-05	0.000286	CcSEcCtD
